Imaging glucose metabolism in perfluorocarbon-perfused hepatocyte bioreactors using positron emission tomography

In vitro hepatocyte bioreactor functionality depends particularly on maintaining appropriate oxygen levels and exposure to nonparenchymal cells. An attractive solution without immunological consequences to the patient is incorporating a perfluorocarbon oxygen carrier in the circulating medium and co-culturing hepatocytes with stellate cells. Since bioreactors are normally sealed sterile units, demonstrating metabolic functionality is hindered by limited access to the cells after their aggregation in the matrix. A novel possibility is to use positron emission tomography (PET) to image cellular radioactive glucose uptake under O2-limited conditions. In this study, primary cell isolation procedures were carried out on eight pigs. Pairs of cell-seeded and cell-free (control) bioreactors with and without perfluorocarbon were cultured under identical conditions and were oxygenated using hypoxic (5% O2) and ambient (20% O2) gas mixes. Sixteen PET scans were conducted 24 h after cell isolation, the same timescale as that involved in treating a liver failure patient with a primary-cell bioreactor. In all cases, cell-seeded bioreactors without perfluorocarbon were more radioactive, i.e., were more glycolytic, than those with perfluorocarbon. This difference was significant in the hypoxic pair of bioreactors but not in the ambient pair of bioreactors. Additionally, in the same hypoxic bioreactors, circulating extracellular steady-state glucose levels were significantly lower and lactate levels were higher than those in the ambient bioreactors. Similar findings have been made in other in vitro hepatocyte studies investigating the effects of perfluorocarbons. PET is attractive for studying in situ O2-dependent bioreactor metabolism because of its visual and numerically quantifiable outputs. Longer-term metabolic studies (e.g., 5–10 days) investigating the effect of perfluorocarbon on bioreactor longevity will complement these findings in the future.

[1]  Mehmet Toner,et al.  Oxygen is a factor determining in vitro tissue assembly: Effects on attachment and spreading of hepatocytes , 1994, Biotechnology and bioengineering.

[2]  S. Nyberg,et al.  Staining with fluorescein diacetate correlates with hepatocyte function. , 1993, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[3]  M. Clemens,et al.  Optimizing normoxic conditions in liver devices using enhanced gel matrices , 2008, Biotechnology and bioengineering.

[4]  P. Verdonck,et al.  Three-dimensional Numerical Modeling and Computational Fluid Dynamics Simulations to Analyze and Improve Oxygen Availability in the AMC Bioartificial Liver , 2006, Annals of Biomedical Engineering.

[5]  A Haverich,et al.  Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. , 2003, Biomaterials.

[6]  K. Jungermann,et al.  Hepatocyte heterogeneity in the metabolism of carbohydrates. , 1992, Enzyme.

[7]  B. Pangrle,et al.  Use of Magnetic Resonance Imaging to Analyze the Performance of Hollow‐Fiber Bioreactors , 1992, Annals of the New York Academy of Sciences.

[8]  S. Bhatia,et al.  Formation of steady-state oxygen gradients in vitro: application to liver zonation. , 2003, Biotechnology and bioengineering.

[9]  K. Lowe,et al.  Engineering blood: synthetic substitutes from fluorinated compounds. , 2003, Tissue engineering.

[10]  D. Waxman,et al.  Impact of dimethyl sulfoxide on expression of nuclear receptors and drug-inducible cytochromes P450 in primary rat hepatocytes. , 2004, Archives of biochemistry and biophysics.

[11]  M. Coelho,et al.  Enzymatic method for determining oxygen solubility in perfluorocarbon emulsions , 2005 .

[12]  K. Lowe,et al.  Perfluorochemicals: their applications and benefits to cell culture. , 1998, Trends in biotechnology.

[13]  M. Sakaguchi,et al.  Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers1 , 2003, Transplantation.

[14]  Payam Akhyari,et al.  Bioartificial grafts for transmural myocardial restoration: a new cardiovascular tissue culture concept. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15]  K. Lindros Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. , 1997, General pharmacology.

[16]  Patrick Vermette,et al.  Bioreactors for tissue mass culture: design, characterization, and recent advances. , 2005, Biomaterials.

[17]  Sangeeta N Bhatia,et al.  Improving the next generation of bioartificial liver devices. , 2002, Seminars in cell & developmental biology.

[18]  M. Nieuwoudt,et al.  A Large-Scale Automated Method for Hepatocyte Isolation: Effects on Proliferation in Culture , 2005, Cell transplantation.

[19]  L. Griffith,et al.  Functional behavior of primary rat liver cells in a three-dimensional perfused microarray bioreactor. , 2002, Tissue engineering.

[20]  K. Jungermann,et al.  Long-term effects of physiological oxygen concentrations on glycolysis and gluconeogenesis in hepatocyte cultures. , 1985, European journal of biochemistry.

[21]  C. Normand,et al.  Long‐term maintenance of hepatocyte functional activity in co‐culture: Requirements for sinusoidal endothelial cells and dexamethasone , 1986, Journal of cellular physiology.

[22]  K. Lowe,et al.  Perfluorochemicals and cell biotechnology. , 1997, Artificial cells, blood substitutes, and immobilization biotechnology.

[23]  Susan C. Roberts,et al.  Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons , 2007, Biotechnology and bioengineering.

[24]  K. Jungermann,et al.  Short-term modulation of glycogen metabolism, glycolysis and gluconeogenesis by physiological oxygen concentrations in hepatocyte cultures. , 1983, European journal of biochemistry.

[25]  G. Wilding,et al.  DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. , 1990, Analytical biochemistry.

[26]  William B. Armiger,et al.  Enhancing Oxygen Transfer in Bioreactors by Perfluorocarbon Emulsions , 1991 .

[27]  K. Lowe,et al.  Perfluorochemicals and Cell Culture , 1989, Nature Biotechnology.

[28]  F. S. Moolman,et al.  Optimization of perfluorocarbon emulsion properties for enhancing oxygen mass transfer in a bio-artificial liver support system , 2004 .

[29]  J. Small,et al.  Fluorescent phallotoxins as probes for filamentous actin , 1988, Journal of Muscle Research & Cell Motility.

[30]  J. M. Pimbley,et al.  Magnetic resonance imaging and modeling of flow in hollow-fiber bioreactors , 1990 .

[31]  F. Terrier,et al.  Hollow fiber bioreactor: New development for the study of contrast agent transport into hepatocytes by magnetic resonance imaging , 2004, Biotechnology and Bioengineering.

[32]  K. Shakesheff,et al.  Long-term culture of functional liver tissue: three-dimensional coculture of primary hepatocytes and stellate cells. , 2003, Tissue engineering.

[33]  M. Matsushita,et al.  Optimal oxygen tension conditions for functioning cultured hepatocytes in vitro. , 2008, Artificial organs.

[34]  G. Michalopoulos,et al.  Epidermal growth factor- and hepatocyte growth factor-receptor activity in serum-free cultures of human hepatocytes. , 1999, Journal of hepatology.

[35]  L. Samson,et al.  A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. , 2005, Current drug metabolism.

[36]  Neil Kaplowitz,et al.  Liver biology and pathobiology , 2006, Hepatology.

[37]  K. Jungermann,et al.  Zonation of parenchymal and nonparenchymal metabolism in liver. , 1996, Annual review of nutrition.

[38]  Daniel I. C. Wang,et al.  Enhanced Oxygen Transfer Using Oil‐in‐Water Dispersions a , 1987, Annals of the New York Academy of Sciences.

[39]  S. Bhatia,et al.  In vitro zonation and toxicity in a hepatocyte bioreactor. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[40]  J. Gaylor,et al.  Techniques for Measurement of Oxygen Consumption Rates of Hepatocytes during Attachment and Post-Attachment , 1996, The International journal of artificial organs.

[41]  M E Phelps,et al.  Positron emission tomography provides molecular imaging of biological processes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Palmer,et al.  Convection and Hemoglobin-Based Oxygen Carrier Enhanced Oxygen Transport in a Hepatic Hollow Fiber Bioreactor , 2008, Artificial cells, blood substitutes, and immobilization biotechnology.

[43]  M. Elibol,et al.  Effect of perfluorodecalin as an oxygen carrier on actinorhodin production by Streptomyces coelicolor A3(2) , 1995, Applied Microbiology and Biotechnology.

[44]  R. Chamuleau,et al.  Recent Developments on Human Cell Lines for the Bioartificial Liver , 2002, The International journal of artificial organs.

[45]  Eugénio C. Ferreira,et al.  Image Analysis and Multiphase Bioreactors , 2001 .

[46]  A. Bader,et al.  The influence of medium composition and matrix on long-term cultivation of primary porcine and human hepatocytes. , 2007, Biomolecular engineering.

[47]  P. Verdonck,et al.  Numerical simulation of fluid flow and oxygen transport in a full scale model of the AMC bioartificial liver with an in vitro determined hepatocyte distribution , 2011 .

[48]  M. Yarmush,et al.  Integration of technologies for hepatic tissue engineering. , 2006, Advances in biochemical engineering/biotechnology.

[49]  Andrzej Werynski,et al.  Impact of Oxygenation of Bioartificial Liver Using Perfluorocarbon Emulsion Perftoran on Metabolism of Human Hepatoma C3A Cells , 2008, Artificial cells, blood substitutes, and immobilization biotechnology.

[50]  F. S. Moolman Oxygen Carriers for a Novel Bio-Artificial Liver Support System , 2008 .

[51]  B. Fleshler,et al.  The Liver: Biology and Pathobiology , 1983 .

[52]  Peter Maier,et al.  Cultured rat hepatocytes adapt their cellular glycolytic activity and adenylate energy status to tissue oxygen tension: Influences of extracellular matrix components, insulin and glucagon , 1994, Journal of cellular physiology.

[53]  Robert Bond,et al.  Hepatocyte function in a radial-flow bioreactor using a perfluorocarbon oxygen carrier. , 2005, Artificial organs.

[54]  G. Michalopoulos,et al.  Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium , 1996, The Journal of cell biology.

[55]  A. Keogh,et al.  Evaluation of the Function of Primary Human Hepatocytes Co-Cultured with the Human Hepatic Stellate Cell (HSC) Line LI90 , 1998, The International journal of artificial organs.

[56]  Thorsten Walles,et al.  Experimental generation of a tissue-engineered functional and vascularized trachea. , 2004, The Journal of thoracic and cardiovascular surgery.